Quanterix Corporation (QTRX)

Quanterix Corporation is a biotechnology company that was founded in 2007 by Dr. David Walt. The company is headquartered in Billerica, Massachusetts. Quanterix is renowned for its ultra-sensitive digital immunoassay platform, Simoa (Single Molecule Array), which allows for the detection of proteins and other biomarkers at extremely low levels, enabling advancements in the field of precision health. This technology is particularly significant in areas such as oncology, neurology, and infectious diseases, as it facilitates earlier disease detection and monitoring. Quanterix has made great strides in enhancing disease diagnostics, helping to drive medical research forward. As of recent reports, the company’s revenue has been steadily increasing, reflecting its growing impact and adoption within the healthcare and research communities.